Study Shows GenomeDx's Decipher' Test Effectively Predicts Rapid Metastatic Prostate Cancer
May 8, 2013 | finanznachrichten.de
SAN DIEGO, May 8, 2013 /PRNewswire/ -- GenomeDx Biosciences today announced that data presented by Johns Hopkins University School of Medicine researchers at the 2013 Annual Meeting for the American Urological Association...
Read more...
GenomeDx Decipher metastatic prostate prostatectomy cancer patient RMD nomograms test rapid biochemical study